Quetiapine
Back to searchMolecule Structure
Scientific Name
Quetiapine
Description of the Drug
Quetiapine is a psychotropic agent used for the management of bipolar disorder, schizophrenia, and major depressive disorder.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01224
http://www.drugbank.ca/drugs/DB01224
Brand Name(s)
Atrolak xl, Biquelle xl, Brancico xl, Ebesque xl, Mintreleq xl, Psyquet xl, Seotiapim xl, Seroquel, Seroquel xl, Sondate xl, Tenprolide xl, Zaluron xl
Company Owner(s)
Alkem Laboratories Ltd, Jubilant Generics Ltd, Macleods Pharmaceuticals Ltd, Anchen Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Amneal Pharmaceuticals Of New York Llc, Astrazeneca Uk Ltd, Prinston Pharmaceutical Inc, Torrent Pharmaceuticals Ltd, Rising Pharma Holdings Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Dopamine D2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL217 |
Serotonin 2c (5-HT2c) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL225 |
Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL7932 | ||
PharmGKB | PA451201 | ||
Human Metabolome Database | HMDB0005021 | ||
DrugBank | DB01224 | ||
PubChem: Thomson Pharma | 14756073 | ||
PubChem | 5002 | ||
NMRShiftDB | 20218786 | ||
LINCS | LSM-3543 | ||
Nikkaji | J386.371I | ||
BindingDB | 50095890 | ||
EPA CompTox Dashboard | DTXSID9023546 | ||
DrugCentral | 2337 | ||
Brenda | 34576 | ||
ChemicalBook | CB82709002 | CB6270450 | |
Guide to Pharmacology | 50 | ||
rxnorm | SEROQUEL | QUETIAPINE FUMARATE | QUETIAPINE |
KEGG Ligand | C07397 | ||
ChEBI | 8707 | ||
ZINC | ZINC000019632628 |